Response from the authors of 'Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group'.
Department of Pediatric Dermatology/Allergology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Heidelberglaan 100, Room G02.124, 3584 CX Utrecht, The Netherlands. Electronic address: m.degraaf-10@umcutrecht.nl.
M
M
de Graaf
Department of Pediatric Haematology and Oncology, University Medical Center Utrecht, Heidelberglaan 100, Room G02.124, 3584 CX Utrecht, The Netherlands.
M F
MF
Raphael
Department of Pediatric Plastic Surgery, University Medical Center Utrecht, Heidelberglaan 100, Room G02.124, 3584 CX Utrecht, The Netherlands.
C C
CC
Breugem
Julius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Heidelberglaan 100, Room G02.124, 3584 CX Utrecht, The Netherlands.
M J
MJ
Knol
Department of Pediatric Dermatology/Allergology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Heidelberglaan 100, Room G02.124, 3584 CX Utrecht, The Netherlands.
C A F M
CA
Bruijnzeel-Koomen
Department of Pediatric Plastic Surgery, University Medical Center Utrecht, Heidelberglaan 100, Room G02.124, 3584 CX Utrecht, The Netherlands.
M
M
Kon
Department of Pediatric Cardiology, University Medical Center Utrecht, Heidelberglaan 100, Room G02.124, 3584 CX Utrecht, The Netherlands.
J M P J
JM
Breur
Department of Pediatric Dermatology/Allergology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Heidelberglaan 100, Room G02.124, 3584 CX Utrecht, The Netherlands.
S G M A
SG
Pasmans
D001262:Atenolol / Q000627:therapeutic use*; D005153:Facial Neoplasms / Q000601:surgery*; D005260:Female; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D008297:Male
D001262:Atenolol